1 Min Read
Sept 18 (Reuters) - Can Fite Biopharma Ltd
* Can-Fite files patent application to treat cytokine release syndrome, a potentially life-threatening complication of CAR-T cell therapy Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.